Nuvicare Hives Relief
- Product NDC
- 84324-031
- 11-digit product format
- 843240031
- Labeler code
- 84324
- Product ID
- 84324-031_8a758eab-e855-4cac-85e1-c7df0aa2150d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- FEXOFENADINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NUVICARE LLC
- Application
- ANDA210137
- Marketing category
- ANDA
- Marketing start
- 2026-01-21
- Substance
- FEXOFENADINE HYDROCHLORIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nuvicare Hives Relief
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FEXOFENADINE HYDROCHLORIDE | 180 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2S068B75ZU |
| Rxcui | 997420 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 84324-031-01 | Nuvicare Hives Relief | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 84324-031-01 | 84324003101 | 30 TABLET in 1 BOTTLE (84324-031-01) | 30 tablet | 2026-01-21 | No | No | Current |